Skip to content

Effective and efficient care for patients with anxiety disorders and/or depression in primary care.

The effect of tailoring on the implementation of guideline recommendations for the recognition, diagnosis and allocation of care for patients with anxiety disorder and/or depression in primary care.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON21099
Enrollment
572
Registered
2009-07-15
Start date
2010-06-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety disorders Depressive disorders Angststoornissen Depressieve stoornissen

Interventions

The interventions to be implemented in both groups are derived from the national guidelines for anxiety disorders and depression and comprise the phase of recognition, diagnosis and needs assessment f
2. Making the diagnosis and recording this in the General Practitioner Information System
3. Discussion of the diagnosis and treatment options with the patient and providing psycho-education to diagnosed patients in accordance with the protocol
4. Making the distinction between mild/non-complex problems and severe/complex problems and determining suitable initial treatment on this basis (stepped care allocation), in consultation with the pat

Sponsors

Trimbos-instituut
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The criteria for the inclusion of patients are: 1. Patients from 18 years and older whose first score on the Dutch version of the extended Kessler-10 (EK-10) is 20 or higher and/or at least once a yes on the added questions 11 till 16; 2. Adequate knowledge of the Dutch language; 3. Able to complete questionnaires. The criteria for the inclusion of general practitioners are: 1. Participate in a training; 2. Motivated to perform screening with the Four-dimensional Symptom Questionnaire (4DSQ), stepped care diagnostics and allocation, psychoeducation; 3. The use of a GP Information System (HIS) and the capability to register data; 4. Monitor treated patients; 5. Filling in questionnaires about experienced barriers and used implementation strategies; 6. Agree with an on-site supervision visit.

Exclusion criteria

Exclusion criteria: None.

Design outcomes

Primary

MeasureTime frame
Assessment at the cluster level of recognition of anxiety or depression by the GP in patients screened positive on the EK-10.

Secondary

MeasureTime frame
Outcomes at the patient level: 1. Change in the symptoms of anxiety and depression measured with the Four-dimensional Symptom Questionnaire; the 4DSQ. 2. Change in functioning, measured with the WHO-DASS; 2. Experiences with the care, measured with the QUality Of care Through the Eyes of the patient scale (QUOTE).; 3. Care utilization, illness and work measured with the Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness (TiC-P). Outcomes at general practitioner level are: 1. Increase in registered diagnoses of anxiety and depression; 2. Change in anti-depressant prescribing, number of references, number of consultations for anxiety and depression.

Contacts

Public ContactHenny Sinnema

Trimbos-instituut Department Innovation of Mental Health Care Postbus 725

hsinnema@trimbos.nl+31 (0)30 - 2959225 of 2971131

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)